Teresa Briggs Insider Sale: 364 DOCU Shares Disposed Under 10b5-1 Plan

Rhea-AI Filing Summary

Teresa Briggs, a director of DocuSign, Inc. (DOCU), reported a sale of common stock under a pre-established plan. On 09/11/2025 she disposed of 364 shares at a price of $79.39 per share. Following the reported transaction she beneficially owned 9,170 shares, held directly. The filing indicates the sale was effected pursuant to a Rule 10b5-1 trading plan and the Form 4 was signed by an attorney-in-fact on her behalf.

Positive

• Transaction executed under a Rule 10b5-1 plan, which supports compliance with insider trading rules
• Form 4 discloses key details (date, shares, price, and post-transaction ownership), demonstrating regulatory transparency

Negative

• None.

Insights

Financial Analyst

TL;DR: Small, pre-planned sale by a director; no material change to holdings or evident signal to investors.

The sale of 364 shares at $79.39 represents a modest, routine disposition relative to the reported post-transaction holding of 9,170 shares. The disclosure that the transaction was executed under a Rule 10b5-1 plan reduces concerns about opportunistic insider timing. From a capital-markets perspective, this is a routine insider liquidity event and does not, by itself, provide material information about company fundamentals.

Corporate Governance Expert

TL;DR: Governance processes followed; use of 10b5-1 plan and Form 4 filing demonstrate compliance.

The reporting person is identified as a director and the Form 4 discloses the transaction code and method. The explicit note that the transaction was made pursuant to a Rule 10b5-1 plan and the inclusion of an attorney-in-fact signature indicate adherence to commonly accepted insider-trading controls and disclosure requirements. This filing reflects proper governance practice for insider sales.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Briggs Teresa

(Last) (First) (Middle)

C/O DOCUSIGN, INC.

221 MAIN STREET, SUITE 800

(Street)

SAN FRANCISCO CA 94105

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
DOCUSIGN, INC. [ DOCU ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/11/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/11/2025		S		364(1)	D	$79.39	9,170	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The transaction was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person.

Remarks:

	/s/ Derrick Chapman, Attorney-in-fact	09/11/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Teresa Briggs report on DocuSign (DOCU)?

She reported a sale of 364 shares of DocuSign common stock on 09/11/2025 at a price of $79.39 per share.

Was the sale by Teresa Briggs part of a trading plan?

Yes. The Form 4 states the transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

How many DocuSign shares did Teresa Briggs own after the reported transaction?

Following the reported sale she beneficially owned 9,170 shares, held directly.

What is Teresa Briggs' relationship to DocuSign as reported on the Form 4?

The Form 4 identifies her as a Director of DocuSign.

Who signed the Form 4 for the reporting person?

The Form 4 was signed on behalf of the reporting person by Derrick Chapman, Attorney-in-fact on 09/11/2025.